Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

Woman's World spoke to several medical experts and found Ozempic and GLP-1 medications could be more ... the risk of ...

GLP-1 RA: Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications utilized to treat type 2 diabetes ...

A rapid growth in demand for GLP-1 receptor agonists (RAs) medications has increased scrutiny around the relationship between ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity ... to the rising use of blockbuster GLP-1 RA drugs." Thomas C. Tsai, MD, MPH, senior author ...

A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age ...

The study found a sharp increase in the share of patients who received GLP-1 RAs during the study period, with GLP-1 RA use increasing ... (such as diabetes), these medications have been limited ...

However, critics feel that GLP-1 RA drugs are becoming ‘glamorised’ by celebrities and influencers, including famous faces such as Elon Musk and Oprah Winfrey. Detractors argue that these ...